EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Assessment Of COVID-19 Positive Patients With ST-Segment Elevation Myocardial Infarction During The COVID-19 Pandemic

Hakan Duman, Handan Duman

Journal of Medical Education and Family Medicine · 2025

DOI: 10.62425/jmefm.1559901 ↗
AbstractBibliografische Angaben

Abstract

Objective: The global impact of the coronavirus disease 2019 (COVID-19) pandemic has been shown to adversely affect the cardiovascular system. Investigating the clinical course of patients with ST-segment elevation myocardial infarction (STEMI) associated with COVID-19 infection is crucial to elucidate the mechanisms linking COVID-19 and STEMI. Assessing these patients from both cardiovascular and infection control perspectives is essential for improving clinical outcomes and reducing the burden on healthcare systems. This study aims to provide a comprehensive evaluation of the clinical course of COVID-19-positive STEMI patients. Methods: This single-center, cross-sectional study analyzed 80 STEMI patients who underwent coronary angiography, comprising 38 COVID-19-positive individuals and 42 COVID-19-negative individuals. We assessed admission times, biochemical parameters, door-to-balloon times, angiographic data, length of hospital stay, and in-hospital mortality. Results: The mean age in the COVID-19-positive group was 56.6±10.8 years, whereas that in the COVID-19-negative group was 53.6±10.8 years (P = .238). No significant differences in demographic characteristics were observed between the groups. However, C-reactive protein (CRP), white blood cell (WBC), and baseline troponin levels were significantly greater in the COVID-19-positive group (P < .001, P = .005, and P = .037, respectively). Echocardiographic evaluation revealed a lower ejection fraction (EF) in COVID-19-positive patients than in COVID-19-negative patients (P = .023). Angiographic evaluation revealed a greater thrombus burden and longer pain-to-balloon time in the COVID-19-positive group (P = .001 and P < .001, respectively). The length of hospital stay was also longer in the COVID-19-positive group (P < .001). Conclusion: The findings of increased thrombus burden, prolonged pain-to-balloon time, and extended hospital stays among COVID-19-positive patients underscore the adverse cardiovascular effects of COVID-19. Delayed hospital presentation of patients with cardiovascular symptoms during the pandemic poses a challenge for timely diagnosis and management of critical cardiovascular conditions.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →